Drug trial for recurring gut infection halted early
NCT ID NCT06536465
Summary
This study tested an oral drug called REC-3964 to see if it could prevent repeat C. diff infections in adults who had just finished treatment for one. It was a Phase 2 trial that ended early when the company sponsoring it decided to stop, which they said was not due to safety problems. The goal was to see if the drug was safe and could help people stay infection-free for 8 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GANJ - Toms River - Ocean Family Gastroenterology
Toms River, New Jersey, 08755, United States
-
Southern Star Research Institute, LLC
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.